|

MEM-288 Intratumoral Injection Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Memgen, Inc.1

Indications

  • Cutaneous Squamous Cell Carcinoma1
  • Advanced Cancer1
  • Metastatic Cancer1
  • Merkel Cell Carcinoma1
  • Triple Negative Breast Cancer1

Tampa, Florida1 trial

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Moffitt Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.